GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai InnoStar Bio-tech Co Ltd (SHSE:688710) » Definitions » Capital Expenditure

Shanghai InnoStar Bio-tech Co (SHSE:688710) Capital Expenditure : ¥-262.50 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Shanghai InnoStar Bio-tech Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shanghai InnoStar Bio-tech Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-13 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-262.50 Mil.


Shanghai InnoStar Bio-tech Co Capital Expenditure Historical Data

The historical data trend for Shanghai InnoStar Bio-tech Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai InnoStar Bio-tech Co Capital Expenditure Chart

Shanghai InnoStar Bio-tech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial -71.55 -99.20 -145.99 -234.04 -287.55

Shanghai InnoStar Bio-tech Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.56 -81.44 -67.09 -101.45 -12.51

Shanghai InnoStar Bio-tech Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-262.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai InnoStar Bio-tech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.

Shanghai InnoStar Bio-tech Co Headlines

No Headlines